Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03838263
Title Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer (IMMUNEBOOST)
Acronym IMMUNEBOOST
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Sainte Catherine Avignon 84918 France Details
Hopital Beaujon Clichy 92100 France Details
Centre Léon Bérard Lyon 69373 France Details
Centre Antoine Lacassagne Nice 06189 France Details
Institut Curie Paris 75005 France Details
Hopital Europeen Georges Pompidou Paris 75015 France Details
Hopital Tenon Paris 75970 France Details
Centre Henri Becquerel Rouen 76038 France Details
Hopital Foch Suresnes 92150 France Details
Institut de cancerologie de Lorraine Alexis Vautrin Vandoeuvre-Les-Nancy 54519 France Details
Institut Gustave Roussy Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field